Credit: Getty Images. Zimhi is an opioid antagonist that delivers 5mg/0.5mL naloxone hydrochloride solution in a single-dose, prefilled syringe for intramuscular or subcutaneous use.

The researchers found that although high-dose naloxone formulations have been used in the clinical as well as community settings, standard intramuscular doses of naloxone are sufficient to reverse ...

Learn about the drug’s dosage, form, strength, and more. ... Vivitrol comes as an intramuscular injection that’s given by a healthcare professional every 4 weeks. ... Dosage for opioid dependence.

ZIMHI from Adamis Pharmaceuticals is administered using a single-dose, prefilled syringe that delivers 5 mg of naloxone hydrochloride solution through intramuscular or subcutaneous injection.

The findings. Those who received intramuscular naloxone required a secondary dose in about 9% compared to 23% in the intranasal group. In real-world terms, this means that 7 people with overdose ...

SAN DIEGO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that additional data in a quantitative systems pharmacology model supports the dose ...

During an opioid overdose, a person’s skin, lips and fingertips might start turning blue if they’re lighter-skinned, or gray if they’re darker-skinned. Their eyes might not react to light ...

HealthDay News — For reversal of opioid overdose, higher-concentration intranasal naloxone has similar efficacy to that of intramuscular naloxone administered at the same dose, according to a ...

PHOENIX, Nov. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), today announced that a pharmacokinetic (PK) study (INS012-18-119) of its proprietary intranasal naloxone spray ...

Two advisory committees to the FDA have voted unanimously to recommend that a nasal spray version of the opioid overdose antidote, naloxone, be made available over the counter. CNN Medical Analyst ...